NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR

Published:2018-03 Issue:3 Volume:27 Page:513-528
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Yoshino Jun,Baur Joseph A.,Imai Shin-ichiro

Funder

NIDDK

Longer Life Foundation

NIA

American Federation for Aging Research

Tanaka Fund

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference125 articles.

1. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme;Avalos;Mol. Cell,2005

2. PARP-2 regulates SIRT1 expression and whole-body energy expenditure;Bai;Cell Metab.,2011

3. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation;Bai;Cell Metab.,2011

4. NAD+ metabolism in health and disease;Belenky;Trends Biochem. Sci.,2007

5. The new life of a centenarian: signalling functions of NAD(P);Berger;Trends Biochem. Sci.,2004

Cited by 679 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of NAD+ in Myocardial Ischemia-induced Heart Failure in Sprague-dawley Rats and Beagles;Current Pharmaceutical Biotechnology;2024-12

2. Nicotinamide riboside kinase 2: A unique target for skeletal muscle and cardiometabolic diseases;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-12

3. High-efficient preparation of β-nicotinamide mononucleotides by crude enzymes cascade catalytic reaction;Enzyme and Microbial Technology;2024-10

4. Potential Therapeutic Interventions Targeting NAD+ Metabolism for ALS;Cells;2024-09-09

5. Spatial regulation of NMN supplementation on brain lipid metabolism upon subacute and sub-chronic PM exposure in C57BL/6 mice;Particle and Fibre Toxicology;2024-09-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3